Oriental Carbon & Chemicals Ltd
Incorporated in 1978, Oriental Carbon & Chemicals Ltd sells Chemicals (Insoluble Sulphur, Sulphuric acid) and has other Investments[1]
- Market Cap ₹ 235 Cr.
- Current Price ₹ 231
- High / Low ₹ 415 / 132
- Stock P/E 977
- Book Value ₹ 266
- Dividend Yield 6.05 %
- ROCE 0.88 %
- ROE 0.05 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.87 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 36.3 to 18.8 days.
- Company's working capital requirements have reduced from 541 days to 24.9 days
Cons
- The company has delivered a poor sales growth of -22.4% over past five years.
- Company has a low return on equity of 1.74% over last 3 years.
- Earnings include an other income of Rs.9.21 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
331 | 347 | 307 | 332 | 369 | 432 | 387 | 384 | 444 | 536 | 82 | 109 | |
261 | 277 | 228 | 245 | 266 | 304 | 282 | 257 | 356 | 425 | 63 | 95 | |
Operating Profit | 70 | 69 | 79 | 86 | 103 | 128 | 105 | 126 | 88 | 110 | 19 | 14 |
OPM % | 21% | 20% | 26% | 26% | 28% | 30% | 27% | 33% | 20% | 21% | 24% | 13% |
7 | 12 | 4 | 6 | 4 | 6 | 9 | 3 | 8 | 2 | 39 | 9 | |
Interest | 14 | 10 | 8 | 7 | 9 | 9 | 10 | 7 | 8 | 13 | 0 | 1 |
Depreciation | 13 | 16 | 17 | 17 | 18 | 20 | 21 | 22 | 24 | 29 | 3 | 4 |
Profit before tax | 50 | 55 | 59 | 69 | 80 | 106 | 83 | 100 | 63 | 70 | 55 | 18 |
Tax % | 19% | 18% | 22% | 30% | 29% | 28% | 9% | 17% | 27% | 24% | 3% | 29% |
41 | 45 | 46 | 48 | 57 | 77 | 75 | 83 | 46 | 54 | 53 | 13 | |
EPS in Rs | 39.31 | 46.88 | 48.08 | 49.74 | 55.17 | 75.13 | 73.14 | 79.00 | 43.07 | 48.64 | 49.48 | 10.47 |
Dividend Payout % | 18% | 18% | 18% | 20% | 18% | 16% | 14% | 18% | 32% | 29% | 28% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -11% |
5 Years: | -22% |
3 Years: | -37% |
TTM: | 33% |
Compounded Profit Growth | |
---|---|
10 Years: | -41% |
5 Years: | -68% |
3 Years: | -82% |
TTM: | 101% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 3% |
3 Years: | 3% |
1 Year: | -42% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 6% |
3 Years: | 2% |
Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 197 | 234 | 273 | 326 | 371 | 399 | 455 | 523 | 551 | 592 | 627 | 256 |
120 | 107 | 86 | 111 | 122 | 132 | 154 | 185 | 189 | 167 | 1 | 3 | |
78 | 88 | 82 | 79 | 85 | 91 | 78 | 96 | 115 | 117 | 257 | 57 | |
Total Liabilities | 405 | 439 | 451 | 527 | 589 | 631 | 697 | 814 | 865 | 886 | 896 | 327 |
222 | 215 | 207 | 327 | 328 | 361 | 354 | 342 | 453 | 478 | 70 | 69 | |
CWIP | 2 | 4 | 40 | 3 | 40 | 3 | 25 | 113 | 41 | 1 | 0 | 0 |
Investments | 11 | 27 | 16 | 38 | 61 | 93 | 133 | 185 | 181 | 225 | 246 | 221 |
169 | 193 | 189 | 159 | 160 | 174 | 185 | 173 | 190 | 181 | 580 | 37 | |
Total Assets | 405 | 439 | 451 | 527 | 589 | 631 | 697 | 814 | 865 | 886 | 896 | 327 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
53 | 70 | 70 | 82 | 94 | 93 | 115 | 91 | 61 | 105 | 97 | 8 | |
-21 | -31 | -40 | -82 | -74 | -49 | -85 | -129 | -41 | -54 | -43 | 12 | |
-34 | -34 | -38 | -2 | -12 | -50 | -10 | 16 | -21 | -52 | -54 | -18 | |
Net Cash Flow | -2 | 5 | -9 | -2 | 8 | -6 | 20 | -21 | -0 | -1 | 1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71 | 71 | 72 | 93 | 80 | 75 | 67 | 77 | 71 | 56 | 35 | 19 |
Inventory Days | 157 | 149 | 197 | 162 | 169 | 152 | 134 | 168 | 151 | 118 | 128 | 126 |
Days Payable | 73 | 83 | 77 | 94 | 91 | 63 | 61 | 88 | 70 | 44 | 69 | 58 |
Cash Conversion Cycle | 155 | 137 | 193 | 160 | 158 | 165 | 140 | 156 | 152 | 130 | 93 | 87 |
Working Capital Days | 66 | 61 | 70 | 78 | 66 | 73 | 70 | 86 | 84 | 74 | 1,526 | 25 |
ROCE % | 18% | 19% | 18% | 18% | 18% | 22% | 15% | 16% | 9% | 11% | -3% | 1% |
Documents
Announcements
No data available.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Jan 2020TranscriptNotesPPT
-
Oct 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Jul 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
-
Jul 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Dec 2015TranscriptNotesPPT
Business Overview:[1][2]
OCCL belongs to the Duncan JP Goenka Group of Companies. It is an ISO40001 and ISO45001 certified manufacturer of customised and value added grades of Insoluble Sulphur.